PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis

BACKGROUND: Daily experience tells us that breast cancer can be controlled using standard protocols up to the advent of a relapse. Now new frontiers in precision medicine like liquid biopsy of cell free DNA (cfDNA) give us the possibility to understand cancer evolution and pick up the key mutation o...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmieri, Maria, Baldassarri, Margherita, Fava, Francesca, Fabbiani, Alessandra, Campennì, Giuseppe Maria, Mencarelli, Maria Antonietta, Tita, Rossella, Marsili, Stefania, Renieri, Alessandra, Frullanti, Elisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819469/
https://www.ncbi.nlm.nih.gov/pubmed/31673247
http://dx.doi.org/10.1186/s12935-019-0991-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6819469/
https://www.ncbi.nlm.nih.gov/pubmed/31673247
http://dx.doi.org/10.1186/s12935-019-0991-y

Ejemplares similares